Diphen Power Tourpen Plaster (Flurbiprofen)

Adult dosage

Remove the release liner from the patch and apply it to the affected area twice daily.

This medication is made from the active ingredient flurbiprofen. This medication should not be used by certain patients. Especially, individuals who have had allergic reactions to this medication or other flurbiprofen formulations should not use it. Additionally, people who have experienced asthma attacks caused by medications known as aspirin-induced asthma or have a history of such should avoid using this medication as it may trigger asthma attacks. Patients with bronchial asthma should exercise caution when using this medication due to the risk of asthma attacks. If symptoms such as redness of the skin, rash, itching, or burning sensation occur while using this medication, it should be discontinued immediately. Furthermore, if early symptoms of an asthma attack occur, such as wheezing or difficulty breathing, use must be stopped immediately and medical consultation should be sought. This medication serves as a treatment for symptom relief and is not a cure for the underlying cause. When applying this medication to areas with skin infections, it should be used in conjunction with antibiotics or antifungals while closely monitoring the condition to prevent worsening of the infection. When using for chronic diseases such as degenerative arthritis, other treatment methods should also be considered in addition to this medication, and careful monitoring for side effects should be conducted. During the early and mid-pregnancy stages, use should be avoided unless absolutely necessary, and if required, the dosage should be minimized and the treatment duration should be kept short. In the late stages of pregnancy, this medication should not be used as it may harm the fetus's heart, lungs, and kidneys, and may increase the risk of bleeding during delivery and delay labor. Its safety in children has not been sufficiently established, and caution is advised due to limited experience. In elderly patients, the skin condition should be closely monitored, and this medication should be used cautiously. This medication should not be applied to damaged skin or mucous membranes, areas with eczema or rashes, and the area should be cleaned of sweat before application.

• Erythema
• rash
• urticaria
• itching
• burning sensation
• contact dermatitis
• dry blister sound
• wheezing
• shortness of breath
• asthma attack

This medication may be sensitive to light, so it should be stored in a container that does not allow light in. Additionally, it is advisable to store the medication at room temperature, preferably between 1°C and 30°C, ensuring the effectiveness of the medication is maintained.

Appearance

This medication is a transdermal patch coated with a colorless to pale yellow adhesive substance covered with a removable film on the solid side.

Package unit

12 sheets/package